1. Home
  2. EVGN

EVGN

Evogene Ltd

Logo Evogene Ltd

Industrials

Agricultural Chemicals

Nasdaq

as 04-11-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.

Founded: 1999 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 39.5M IPO Year: N/A
Target Price: $3.62 AVG Volume (30 days): 173.6K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.52 EPS Growth: N/A
52 Week Low/High: $0.45 - $1.44 Next Earning Date: 05-16-2024
Revenue: $5,640,000 Revenue Growth: 236.72%
Revenue Growth (this year): 207.45% Revenue Growth (next year): 85.29%

Share on Social Networks: